Pharmafile Logo
Pharmafocus logo
Advanced Search

Takeda

Showing 15 posts of 249 posts found.

entrance_takeda_i020_v1

Takeda invests $125m in Maverick T-cell platform partnership

January 12, 2017
Research and Development Maverick, Takeda

Takeda has announced its intention to invest $125 million in a partnership with Maverick Therapeutics to develop the latter’s T-cell …

News
takeda_tokyo_hq

Takeda to acquire Ariad in $5.2 billion deal

January 9, 2017
Manufacturing and Production, Sales and Marketing Ariad, Takeda

Takeda has acquired US drug maker, Ariad Pharmaceuticals, in a deal worth $5.2 billion. Takeda has been looking to bolster …

News
entrance_takeda_i020_v1

Takeda to invest €40m in Dublin operations expansion

December 5, 2016
Manufacturing and Production Dublin, Ireland, Nanlarotm, Takeda

Takeda has announced it is to invest $40 million in a new facility in Dublin, adding a new facility and …

News
takeda_tokyo_hq

Takeda to build €100 million dengue vaccine manufacturing plant

December 1, 2016
Manufacturing and Production, Medical Communications Takeda, dengue, phase 3

Takeda have announced plans to spend more than €100 million in the construction of a new manufacturing plant in Singen, …

News
takeda_tokyo_hq

Takeda gains marketing authorisation for multiple myeloma pill

November 28, 2016
Sales and Marketing Takeda, multiple myeloma

Takeda Pharmaceutical has announced that they have received conditional marketing authorisation for Ninlaro (ixazomib) for treatment of adult patients with …

News
marc_weeks_takeda

Takeda appoint Marc Weeks to Digital Lead role

October 31, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, digital

Takeda UK have appointed Marc Weeks to the newly created role of digital lead. The creation of the role comes as …

Appointment
takeda_world

Takeda enters $790m cancer development deal

October 11, 2016
Manufacturing and Production, Research and Development Cancer, Crescendo Biologics, Takeda, clinical partnership, humabody

Takeda and Crescendo Biologics have shaken hands on a $790 million deal to develop and commercialise cancer therapeutics using Crescendo’s …

News
takeda_world

Takeda partners with Zydus to develop chikungunya vaccine

September 20, 2016
Manufacturing and Production, Research and Development Takeda, Zydus Cadila, chikungunya

Zydus Cadila has teamed up with Takeda to develop a vaccine for the chikungunya virus. Zydus Cadila’s group firm Cadila …

News
4420456374_64a3d7e6aa

Top Ten articles in the Pharma Industry this week

September 16, 2016
Medical Communications Bayer, GSK, Gilead, GlaxoSmithKline, J&J, JJ, Pfizer, Roche, Sanofi, Takeda, aspen, google, monsanto

As we come to the end of another week, we’re looking back at an exciting week in the industry; there …

News
entrance_takeda_i020_v1

Takeda reportedly sets $15bn on US acquisitions

September 14, 2016
Manufacturing and Production, Research and Development Takeda, acquisitions

Takeda Pharmaceuticals is reportedly willing to spend as much as $15 billion on acquisitions in the US in efforts to …

News
takeda_world

Takeda forms “first of its kind” developmental partnership with CRO

September 13, 2016
Manufacturing and Production, Research and Development PRA Health Services, Takeda, partnership

Takeda and PRA Health Services have announced a new partnership that will see the Japanese pharma giant transfer 300 staffers …

News
takeda_tokyo_hq

Takeda begins Phase III dengue vaccine trial

September 8, 2016
Research and Development Takeda, Vaccine, dengue, dengue vaccine, phase III, trial

Takeda Pharmaceuticals has announced the initiation of a global Phase III clinical trial to test its live-attenuated tetravalent dengue vaccine …

News
rd_hands

Takeda secures $312 million zika vaccine development contract

September 5, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Takeda, US government, Zika, world health organization

Takeda has announced that it has been granted a $312 million contract from the US government to develop an inactivated, …

News
takeda_tokyo_hq

Jobs to go at Takeda as it shuts down Cambridge facility

August 26, 2016
Manufacturing and Production, Medical Communications Cambridge, Jobs, Takeda, closure

Takeda has announced plans to close its facility in Cambridge in the UK, to refocus its research and development operations …

News
takeda_tokyo_hq

Old CDF drug not recommended in initial NICE guidance due to lack of evidence

August 10, 2016
Research and Development, Sales and Marketing Adcetris, Cancer Drugs Fund, NICE, Takeda, hodgkin's lymphoma

The National Institute for Health and Care Excellence (NICE) has published draft guidance not recommending Takeda’s Adectris (brentuximab vedotin), despite …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026